| Net Cash Provided by (Used in) Operating Activities |
75K |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-50K |
USD |
|
Q4 2023 |
Q1 2025 |
| Common Stock, Shares Authorized |
681M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
231M |
shares |
+2.33% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
75K |
USD |
|
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.15M |
USD |
+3.98% |
Q2 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
12K |
USD |
|
Q3 2023 |
FY 2023 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
6K |
USD |
|
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
35M |
USD |
0% |
Q3 2023 |
FY 2023 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
FY 2023 |
| Preferred Stock, Shares Authorized |
10M |
shares |
|
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
22.6M |
USD |
+1.68% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
555K |
USD |
+1.84% |
Q4 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q3 2025 |